Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2025 | Q4 2025 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/29/2024 | Q2 2025 | N/A | -$0.14 | N/A | N/A | $0 |
| 06/29/2024 | Q4 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 12/29/2023 | Q2 2024 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/30/2023 | Q4 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/30/2022 | Q2 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2022 | Q4 2022 | N/A | -$0.01 | N/A | N/A | $-2,341,800,000 |
| 12/30/2021 | Q2 2022 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/30/2020 | Q2 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/30/2020 | Q4 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/30/2019 | Q2 2020 | N/A | -$0.00 | N/A | N/A | $0 |
The conference call for Regencell Bioscience Holdings Ltd's latest earnings report can be listened to online.
The conference call transcript for Regencell Bioscience Holdings Ltd's latest earnings report can be read online.
Regencell Bioscience Holdings Ltd (:RGC) has a recorded net income of $-3,584,213.Regencell Bioscience Holdings Ltd has generated $-0.0072 earnings per share over the last four quarters.
Regencell Bioscience Holdings Ltd (:RGC) has a price-to-earnings ratio of -3976.09 and price/earnings-to-growth ratio is -39.76.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED